Skip to main content

Nocturia

Nocturia is the need to wake from sleep one or more times to void. A single nocturnal void is common, especially with aging, but two or more voids per night is the usual threshold for clinically meaningful bother, sleep disruption, fall risk, and health consequences.[1][2][3]

For the reconstructive urologist and urogynecologist, nocturia is a trap for prostate- or bladder-only thinking. It can come from nocturnal urine overproduction, reduced bladder capacity, incomplete emptying, sleep apnea, insomnia, edema mobilization, diabetes, kidney disease, heart failure, medications, or mixed physiology. The bladder diary, not the cystoscope, is the first real diagnostic test.

Definition and Terminology​

Nocturia requires sleep before and after the void. A patient who is awake for insomnia and voids opportunistically has a different problem than a patient awakened by bladder filling.[1][2]

TermDefinitionPractical use
NocturiaWaking from sleep to void one or more timesSymptom; count episodes per night
Nocturnal polyuria (NP)Excess nocturnal urine production: >20% of 24-hour urine volume in younger adults or >33% in older adultsMost common physiologic driver; diagnose by bladder diary
Global polyuria24-hour urine output >40 mL/kgThink diabetes mellitus, diabetes insipidus, polydipsia, excessive fluid intake
Reduced bladder capacityFunctional capacity too low for overnight urine productionOAB, BOO, cystitis, fibrosis, neurogenic bladder, pain syndromes
Nocturia index (Ni)Nocturnal urine volume / maximum voided volumeEstimates expected nocturnal voids
Nocturnal polyuria index (NPi)Nocturnal urine volume / 24-hour urine volumeQuantifies nocturnal urine fraction
First uninterrupted sleep period (FUSP)Time from sleep onset to first nocturnal voidSleep-quality outcome; often more meaningful than total void count

Epidemiology​

Nocturia is one of the most common lower urinary tract symptoms and rises sharply with age.[2][4][5]

GroupPattern
Young adultsOne nocturnal void is common; two or more voids are less common but still clinically important when bothersome
Women under midlifeOften report nocturia more frequently than similarly aged men
Older adultsPrevalence increases in both sexes; many adults in their 70s and 80s wake at least once nightly
Men with LUTSNocturia is often attributed to BPH, but nocturnal polyuria and sleep disorders frequently dominate

Population-based data from China, South Korea, and Taiwan found nocturia with two or more voids in approximately one-third of adults aged 40 years or older, with similar rates in men and women.[6] Incidence increases with age, while remission is possible, especially when contributing medical or behavioral drivers are corrected.[7]

Risk factors associated with nocturia include older age, obesity, diabetes, hypertension, cardiovascular disease, obstructive sleep apnea, depression, erectile dysfunction, childhood enuresis history, and metabolic syndrome.[6][8]

Pathophysiology​

Nocturia reflects a mismatch between nocturnal urine production, bladder storage capacity, and sleep architecture.[9][10][11]

Nocturnal polyuria​

Nocturnal polyuria is excessive urine production during the sleep period despite normal 24-hour output. Mechanisms include:

  • Impaired nocturnal arginine vasopressin (AVP) rise — less overnight water conservation
  • Peripheral edema mobilization — leg fluid returns to the intravascular space when supine
  • Atrial natriuretic peptide release — promotes natriuresis and diuresis
  • Obstructive sleep apnea — negative intrathoracic pressure and hypoxia increase ANP and nocturnal urine production
  • Cardiovascular or renal disease — daytime fluid retention with nighttime redistribution[10][11][12][13]

Reduced bladder capacity​

Nocturia can occur when the overnight bladder capacity is lower than the nocturnal urine load. Causes include OAB, detrusor overactivity, bladder outlet obstruction, high post-void residual, neurogenic bladder, painful bladder syndrome, radiation or inflammatory bladder fibrosis, and some nocturnal-specific capacity patterns.[9][14]

Global polyuria​

Global polyuria means the patient makes too much urine across the whole day, not just at night. Common causes include poorly controlled diabetes mellitus, diabetes insipidus, primary polydipsia, excessive fluid intake, hypercalcemia, and some renal concentrating disorders.[3][9]

Sleep disorders​

Some patients wake because of insomnia, arousal disorder, restless legs, pain, or obstructive sleep apnea, then void because they are awake. Others are awakened by bladder filling and then develop secondary sleep fragmentation. The relationship is often bidirectional.[2][15]

Mixed etiology​

Most clinically significant nocturia is mixed. A patient may have nocturnal polyuria from edema and OSA, reduced capacity from OAB, and incomplete emptying from BPH or underactive bladder. Treating only one axis explains many disappointments in nocturia care.[3][16]

The Sleep CALM framework is useful:

  • Sleep disorders
  • Comorbidities: cardiovascular, renal, endocrine, neurologic
  • Actions: fluids, caffeine, alcohol, salt, evening habits
  • Lower urinary tract dysfunction
  • Medications[15]

Health Consequences​

Nocturia is not just nuisance waking. It is associated with sleep fragmentation, impaired daytime function, depression, falls, fractures, and mortality.[2][9]

ConsequenceEvidence signal
Sleep disruptionShorter FUSP and repeated waking correlate with poor sleep quality and daytime dysfunction
Falls and fracturesMeta-analysis shows increased risk of falls and a possible increase in fractures among patients with nocturia
MortalityMeta-analysis shows nocturia is associated with higher all-cause mortality; association does not prove causality but should trigger systemic evaluation
Work and cognitionSleep interruption worsens productivity, concentration, and quality of life

The fall-risk signal matters most in older adults: urgency, darkness, orthostasis, sedatives, mobility limits, and nighttime bathroom trips are a dangerous combination.[17][18]

Diagnostic Evaluation​

History and Examination​

Key history points:

  • Number of nocturnal voids and timing of the first void
  • Whether the patient wakes to void or voids because already awake
  • Fluid, caffeine, alcohol, salt, and evening intake pattern
  • Diuretic timing and other medications
  • Snoring, witnessed apneas, morning headaches, daytime sleepiness, insomnia
  • Leg edema, heart failure, kidney disease, hypertension, diabetes
  • LUTS: urgency, frequency, UUI, weak stream, hesitancy, straining, incomplete emptying
  • UTIs, hematuria, pelvic pain, neurologic disease

Physical examination should look for peripheral edema, obesity or sleep-apnea phenotype, blood pressure abnormalities, cardiopulmonary signs, abdominal distension, pelvic organ prolapse when relevant, prostate enlargement when relevant, and focused neurologic findings.[3][9][15]

Frequency-Volume Chart​

A 2- to 3-day frequency-volume chart (FVC) is the cornerstone test. It should record:

  • Time and volume of each void
  • Sleep time and wake time
  • Fluid intake timing, type, and volume
  • Incontinence episodes and urgency when relevant
  • Diuretic timing

Derived calculations:

CalculationFormulaInterpretation
24-hour urine outputSum of all urine over 24 hours>40 mL/kg suggests global polyuria
Nocturnal urine volumeNighttime voids plus first morning voidUsed for nocturnal polyuria calculation
NPiNocturnal urine volume / 24-hour urine volume>20% young or >33% older adult suggests NP
MVVLargest single voided volumeProxy for functional bladder capacity
NiNocturnal urine volume / MVVEstimates expected nocturnal void count

The diary also prevents a common error: treating nocturia as OAB or BPH when the real problem is nighttime urine overproduction.[1][3][19]

Laboratory and Ancillary Testing​

Common tests include:

  • Urinalysis +/- urine culture
  • Serum sodium, creatinine/eGFR, glucose or A1c
  • Calcium when global polyuria is unexplained
  • PSA in selected men based on age, risk, and prostate evaluation
  • BNP or cardiac evaluation when heart failure is suspected
  • PVR when voiding symptoms, OAB medication, antidiuretic therapy, or outlet surgery is being considered

Screen for OSA with STOP-BANG or equivalent when snoring, obesity, witnessed apneas, resistant hypertension, morning headaches, daytime sleepiness, or refractory nocturnal polyuria is present. Urodynamics are not routine for nocturia, but are appropriate when the diary and symptoms suggest BOO, detrusor underactivity, neurogenic dysfunction, refractory OAB, or unclear bladder capacity limitation.[9][15][20]

Management​

Behavioral and Comorbidity Treatment​

First-line treatment targets the driver identified by history and FVC:

  • Reduce evening fluids, especially 2-4 hours before bedtime
  • Limit evening caffeine and alcohol
  • Reduce high evening salt intake
  • Move diuretics to mid- or late afternoon when medically appropriate
  • Elevate legs in the afternoon for dependent edema
  • Use daytime compression stockings for venous insufficiency or edema
  • Optimize diabetes, hypertension, CKD, heart failure, and sleep apnea
  • Treat constipation and mobility barriers
  • Improve bathroom safety: lighting, assistive devices, bedside commode when needed[3][15][21]

For edema-driven nocturnal polyuria, afternoon leg elevation and compression can shift diuresis earlier in the day. In selected patients, a clinician may time a loop diuretic in the afternoon to mobilize fluid before sleep; this requires attention to blood pressure, renal function, electrolytes, and fall risk.[3]

Desmopressin for Nocturnal Polyuria​

Desmopressin is a synthetic AVP analogue that reduces nocturnal urine production. It is the most phenotype-specific medication for nocturia due to documented nocturnal polyuria.[4][19][22]

Practical rules:

  • Use only when FVC confirms nocturnal polyuria or the phenotype is otherwise very clear.
  • Check baseline sodium and renal function.
  • Recheck sodium within the first week and periodically thereafter.
  • Avoid or use extreme caution in older adults, CKD, heart failure, uncontrolled hypertension, hyponatremia risk, edema states, and patients taking medications that lower sodium.
  • Do not use more than once in 24 hours.

Desmopressin can reduce nocturnal voids and prolong FUSP, but the dominant safety issue is hyponatremia. The 2023 AGS Beers Criteria alternatives paper recommends avoiding desmopressin for nocturia/nocturnal polyuria in older adults because safer non-drug approaches and comorbidity-directed treatments are preferred.[21][22][23]

OAB and Reduced Capacity Treatment​

When the diary shows small nocturnal voided volumes, urgency, or daytime storage symptoms, treat the storage phenotype:

  • Bladder training and urgency suppression
  • Pelvic-floor therapy when pelvic-floor overactivity or mixed incontinence is present
  • Beta-3 agonist when medication is appropriate, especially in older adults
  • Antimuscarinic therapy selectively, with caution about cognitive effects, constipation, dry mouth, and retention
  • Intradetrusor botulinum toxin or neuromodulation for refractory OAB/UUI after appropriate evaluation

See Urgency Incontinence & OAB for the broader storage pathway.

Men With BPH or Outlet Symptoms​

Alpha-blockers, 5-alpha reductase inhibitors, and outlet procedures can improve nocturia when bladder outlet obstruction is a meaningful contributor, but many men continue to wake if nocturnal polyuria, OSA, edema, or insomnia is untreated. Nocturia in men should be evaluated independently rather than assumed to be prostate-driven.[24]

See Benign Prostatic Hyperplasia and Primary Bladder Neck Obstruction when the diary and flow/PVR suggest outlet disease.

Obstructive Sleep Apnea​

OSA treatment can improve nocturia, especially when nocturnal polyuria is present. CPAP reduces negative intrathoracic pressure, decreases ANP-mediated nocturnal diuresis, and improves sleep continuity.[12][20][25][26]

CPAP studies show reductions in nocturnal voids, nocturnal urine volume, NPi, and clinically relevant nocturia in OSA populations.[20][25][26][27] Refractory nocturia with snoring, obesity, resistant hypertension, or daytime sleepiness deserves a sleep evaluation, not another bladder medication.

Special Considerations​

Older and Frail Adults​

Prioritize fall prevention, lighting, mobility support, medication review, edema control, and systemic disease management. Avoid anticholinergic burden when possible. Desmopressin is usually a last-line or avoided option because hyponatremia can be catastrophic.[17][18][21]

Women​

Assess for OAB, nocturnal polyuria, sleep disorders, edema, genitourinary syndrome of menopause, prolapse, recurrent UTI, and pain syndromes. Vaginal estrogen can help GSM-associated urgency/frequency, but it is not a nocturnal polyuria treatment.

Men​

Nocturia is often the symptom that brings men to urology, but prostate treatment alone commonly underdelivers. Use the diary before escalating BPH medications or surgery.[24]

Systemic Disease Signal​

New or worsening nocturia may be the first visible sign of sleep apnea, heart failure, CKD, diabetes, poorly controlled hypertension, edema, or medication harm. A urology visit should become the doorway to medical optimization when the diary points outside the bladder.

See Also​

References​

1. Van Kerrebroeck P, Andersson KE. "Terminology, epidemiology, etiology, and pathophysiology of nocturia." Neurourology and Urodynamics. 2014;33 Suppl 1:S2-S5. doi:10.1002/nau.22595

2. Bliwise DL, Wagg A, Sand PK. "Nocturia: a highly prevalent disorder with multifaceted consequences." Urology. 2019;133S:3-13. doi:10.1016/j.urology.2019.07.005

3. Oelke M, De Wachter S, Drake MJ, et al. "A practical approach to the management of nocturia." International Journal of Clinical Practice. 2017;71(11):e13027. doi:10.1111/ijcp.13027

4. Weiss JP, Everaert K. "Management of nocturia and nocturnal polyuria." Urology. 2019;133S:24-33. doi:10.1016/j.urology.2019.09.022

5. Bosch JLHR, Weiss JP. "The prevalence and causes of nocturia." The Journal of Urology. 2013;189(1 Suppl):S86-S92. doi:10.1016/j.juro.2012.11.033

6. Chow PM, Liu SP, Chuang YC, et al. "The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study." World Journal of Urology. 2018;36(11):1853-1862. doi:10.1007/s00345-018-2329-0

7. Pesonen JS, Cartwright R, Mangera A, et al. "Incidence and remission of nocturia: a systematic review and meta-analysis." European Urology. 2016;70(2):372-381. doi:10.1016/j.eururo.2016.02.014

8. Azuero J, Santander J, Trujillo CG, et al. "Potential associations of adult nocturia: results from a national prevalence study." Neurourology and Urodynamics. 2021;40(3):819-828. doi:10.1002/nau.24624

9. Dani H, Esdaille A, Weiss JP. "Nocturia: aetiology and treatment in adults." Nature Reviews Urology. 2016;13(10):573-583. doi:10.1038/nrurol.2016.134

10. Birder LA, Van Kerrebroeck PEV. "Pathophysiological mechanisms of nocturia and nocturnal polyuria: the contribution of cellular function, the urinary bladder urothelium, and circadian rhythm." Urology. 2019;133S:14-23. doi:10.1016/j.urology.2019.07.020

11. Weiss JP, Monaghan TF, Epstein MR, Lazar JM. "Future considerations in nocturia and nocturnal polyuria." Urology. 2019;133S:34-42. doi:10.1016/j.urology.2019.06.014

12. Niimi A, Suzuki M, Yamaguchi Y, et al. "Sleep apnea and circadian extracellular fluid change as independent factors for nocturnal polyuria." The Journal of Urology. 2016;196(4):1183-1189. doi:10.1016/j.juro.2016.04.060

13. Miyazato M, Tohyama K, Touyama M, et al. "Effect of continuous positive airway pressure on nocturnal urine production in patients with obstructive sleep apnea syndrome." Neurourology and Urodynamics. 2017;36(2):376-379. doi:10.1002/nau.22936

14. Presicce F, Puccini F, De Nunzio C, et al. "Variations of nighttime and daytime bladder capacity in patients with nocturia: implication for diagnosis and treatment." The Journal of Urology. 2019;201(5):962-966. doi:10.1097/JU.0000000000000022

15. Monaghan TF, Weiss JP, Wein AJ, et al. "Sleep disorders, comorbidities, actions, lower urinary tract dysfunction, and medications ('Sleep C.A.L.M.') in the evaluation and management of nocturia: a simple approach to a complex diagnosis." Neurourology and Urodynamics. 2023;42(3):562-572. doi:10.1002/nau.25128

16. Yoon JH, Lee K, Park EJ, et al. "Analysis of changes in the pathophysiology of nocturia according to the number of nocturia episode, age, and gender using frequency volume charts: a retrospective observational study." Medicine. 2022;101(43):e31295. doi:10.1097/MD.0000000000031295

17. Pesonen JS, Vernooij RWM, Cartwright R, et al. "The impact of nocturia on falls and fractures: a systematic review and meta-analysis." The Journal of Urology. 2020;203(4):674-683. doi:10.1097/JU.0000000000000459

18. Pesonen JS, Cartwright R, Vernooij RWM, et al. "The impact of nocturia on mortality: a systematic review and meta-analysis." The Journal of Urology. 2020;203(3):486-495. doi:10.1097/JU.0000000000000463

19. Homma Y. "Classification of nocturia in the adult and elderly patient: a review of clinical criteria and selected literature." BJU International. 2005;96 Suppl 1:8-14. doi:10.1111/j.1464-410X.2005.05655.x

20. Vrooman OPJ, van Balken MR, van Koeveringe GA, et al. "The effect of continuous positive airway pressure on nocturia in patients with obstructive sleep apnea syndrome." Neurourology and Urodynamics. 2020;39(4):1124-1128. doi:10.1002/nau.24329

21. Steinman MA. "Alternative treatments to selected medications in the 2023 American Geriatrics Society Beers Criteria." Journal of the American Geriatrics Society. 2025;73(9):2657-2677. doi:10.1111/jgs.19500

22. Ebell MH, Radke T, Gardner J. "A systematic review of the efficacy and safety of desmopressin for nocturia in adults." The Journal of Urology. 2014;192(3):829-835. doi:10.1016/j.juro.2014.03.095

23. Han J, Jung JH, Bakker CJ, Ebell MH, Dahm P. "Desmopressin for treating nocturia in men." Cochrane Database of Systematic Reviews. 2017;10:CD012059. doi:10.1002/14651858.CD012059.pub2

24. Orlando AP, Maciejko LA, Lerner LB. "Nocturia in men: is the prostate really to blame?" Urologic Clinics of North America. 2025;52(4):581-594. doi:10.1016/j.ucl.2025.07.011

25. Miyauchi Y, Okazoe H, Okujyo M, et al. "Effect of the continuous positive airway pressure on the nocturnal urine volume or night-time frequency in patients with obstructive sleep apnea syndrome." Urology. 2015;85(2):333-336. doi:10.1016/j.urology.2014.11.002

26. Margel D, Shochat T, Getzler O, Livne PM, Pillar G. "Continuous positive airway pressure reduces nocturia in patients with obstructive sleep apnea." Urology. 2006;67(5):974-977. doi:10.1016/j.urology.2005.11.054

27. Tsubouchi K, Gunge N, Matsuoka W, et al. "Drugs showing real-world efficacy for nocturia in patients with bladder storage symptoms." Anticancer Research. 2023;43(1):455-461. doi:10.21873/anticanres.16182